Anlene products are enriched with a scientifically-formulated mix of calcium and other essential bone nutrients which include vitamin D, zinc, and magnesium to ensure enhanced calcium absorption and bone strength that aid in continued mobility. Anlene has twice as much calcium as regular milk.
Anlene has a 20-year track record as the leading bone health product in Asia. The brand’s mission is to raise awareness of osteoporosis so people can take steps to prevent it through better nutrition and exercise.
In the past 12 months alone, Anlene has conducted more than five million free bone scans across Asia and the Middle East, and partnered with local osteoporosis societies around the world to help raise awareness of maintaining bone health.
To date, Fonterra has spent more than US$50 million on bone health research and US$15 million directly on the development of Anlene, increasing our understanding of osteoporosis and the role of dairy in its prevention. The experts behind Anlene have funded, and been involved with 18 clinical trials relating to bone health.
Fonterra has worked with the International Osteoporosis Foundation (IOF) since 2007 and became IOF’s Regional Nutrition Partner Asia-Pacific in 2010. The partnership is based on a shared vision to increase bone health awareness and education in the Asia Pacific and Middle East regions. Some of the activities Fonterra has supported include the Asia and Middle East/Africa Regional Audits and World Osteoporosis Day activities in various countries across the region.
Anlene is available in 17 countries across Asia, Africa and the Middle East.